Adewunmi Adeoye - Academia.edu (original) (raw)

Papers by Adewunmi Adeoye

Research paper thumbnail of Abstract P6-03-17: Genomic landscape of breast cancers from women of African ancestry across the diaspora

Cancer Research, 2016

Objectives: Of all ethnic/racial groups, age-standardized mortality rate from breast cancer is hi... more Objectives: Of all ethnic/racial groups, age-standardized mortality rate from breast cancer is highest for African American women in the US for reasons that remain understudied. The paucity of genomic studies of breast tumors across the African Diaspora further restricts our understanding of the biology of breast cancer in underserved populations. To gain a better understanding of the genomic landscape of breast cancer in women of African Ancestry, we have developed a cross continent translational research infrastructure to examine the spectrum of genetic alterations in breast tumors from West Africa compared to the spectrum of alterations observed in tumors from African-American and other women who are predominantly white in The Cancer Genome Atlas (TCGA) dataset. Methods: Peripheral blood and breast cancer biopsy tissues were collected from 214 patients enrolled in the West Africa Breast Cancer Study (WABCS) at the University of Ibadan/University College Hospital (UI/UCH) and at L...

Research paper thumbnail of Abstract 1204: Heterogeneity within triple-negative breast cancer (TNBC)

Background: TNBC refers to those breast cancers which are negative for ER, PR and Her2/neu overex... more Background: TNBC refers to those breast cancers which are negative for ER, PR and Her2/neu overexpression, thereby unsuitable for hormone and trastuzumab therapy. Although TNBC overlap with basal-like breast cancers, these terms are not synonymous. We decided, in a single institution cohort, to develop a better understanding of the types of tumors that make up TNBC Materials and Methods: We carried out a clinicopathological study of a cohort of 192 patients diagnosed with TNBC at the University Health Network in 2007. Patient biodata, clinical and histopathological information of proven prognostic importance was retrieved from the records. Tissue microarrays were constructed from duplicate 0.6mm cores of representative tumour tissue and stained with 9 antibodies according to recommended protocols. The TMA slides were interpreted using the Allred method except for the Ki67 staining which was interpreted by the visual estimate method of assessing proportion of nuclei taking up stains. Results were tabulated and summary statistics was done to determine proportions. Results: The age-range is 28 - 99 years. The median and modal age group was 50 -59 years. 70.3% of the patients are aged between 40 and 69 years at the time of diagnosis. The tumour size range was 0.6cm to 16 cm. 41.67% are pT1, 51.04% are pT2 while 6.8% are pT3. Four patients had T4 tumor with skin and nipple involvement. The diagnosis was predominantly invasive ductal carcinoma (IDC) in 84.9% of patients. Metaplastic carcinoma (10.4%), pleomorphic lobular carcinoma (1.5%), and single cases of invasive lobular carcinoma (ILC), tubular, apocrine and poorly differentiated carcinoma were seen. DCIS is a prominent feature in 26.6% of the cases. The number of lymph nodes identified ranged from 0 - 46. 59.90% were in pN0 category, 16.7% in the pN1 category, pN2 - 8.3%, and 15.1% in pN3 category. Extra-nodal metastasis at diagnosis was found in 7.3% of patients. The tumour grade: Grade I - 1.55%, Grade II - 13.47% and Grade III 84.97%. CD44 was positive in 17.71%, p63 - 4.17%, p53 - 51.56%, e-cadherin - 81.77%, Vimentin - 77.60%, Cyclin D1 - 22.40%, BCL-2 - 19.27%, and androgen receptor (AR) - 5.73%. 43.75% of cases show proliferation rates of ≥15%, while 26.04% have proliferation rates of between 5% and ≤14%. Conclusion: While a large proportion of TNBCs show a high proliferation (Ki67, Cyclin D1 and grade III), a substantial number did not show this. This study provides clues to support the current hypothesis that several mechanisms drive the carcinogenesis of TNBC, with a heterogeneous pattern of biomarker expression. Further investigation is needed to better understand the factors driving the development and progression of the different types of TNBC. Citation Format: Adewunmi O. Adeoye, Bruce J. Youngson, Naomi Miller, Susan J. Done. Heterogeneity within triple-negative breast cancer (TNBC). [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1204. doi:10.1158/1538-7445.AM2013-1204

Research paper thumbnail of Abstract 1204: Heterogeneity within triple-negative breast cancer (TNBC)

Background: TNBC refers to those breast cancers which are negative for ER, PR and Her2/neu overex... more Background: TNBC refers to those breast cancers which are negative for ER, PR and Her2/neu overexpression, thereby unsuitable for hormone and trastuzumab therapy. Although TNBC overlap with basal-like breast cancers, these terms are not synonymous. We decided, in a single institution cohort, to develop a better understanding of the types of tumors that make up TNBC Materials and Methods: We carried out a clinicopathological study of a cohort of 192 patients diagnosed with TNBC at the University Health Network in 2007. Patient biodata, clinical and histopathological information of proven prognostic importance was retrieved from the records. Tissue microarrays were constructed from duplicate 0.6mm cores of representative tumour tissue and stained with 9 antibodies according to recommended protocols. The TMA slides were interpreted using the Allred method except for the Ki67 staining which was interpreted by the visual estimate method of assessing proportion of nuclei taking up stains. Results were tabulated and summary statistics was done to determine proportions. Results: The age-range is 28 - 99 years. The median and modal age group was 50 -59 years. 70.3% of the patients are aged between 40 and 69 years at the time of diagnosis. The tumour size range was 0.6cm to 16 cm. 41.67% are pT1, 51.04% are pT2 while 6.8% are pT3. Four patients had T4 tumor with skin and nipple involvement. The diagnosis was predominantly invasive ductal carcinoma (IDC) in 84.9% of patients. Metaplastic carcinoma (10.4%), pleomorphic lobular carcinoma (1.5%), and single cases of invasive lobular carcinoma (ILC), tubular, apocrine and poorly differentiated carcinoma were seen. DCIS is a prominent feature in 26.6% of the cases. The number of lymph nodes identified ranged from 0 - 46. 59.90% were in pN0 category, 16.7% in the pN1 category, pN2 - 8.3%, and 15.1% in pN3 category. Extra-nodal metastasis at diagnosis was found in 7.3% of patients. The tumour grade: Grade I - 1.55%, Grade II - 13.47% and Grade III 84.97%. CD44 was positive in 17.71%, p63 - 4.17%, p53 - 51.56%, e-cadherin - 81.77%, Vimentin - 77.60%, Cyclin D1 - 22.40%, BCL-2 - 19.27%, and androgen receptor (AR) - 5.73%. 43.75% of cases show proliferation rates of ≥15%, while 26.04% have proliferation rates of between 5% and ≤14%. Conclusion: While a large proportion of TNBCs show a high proliferation (Ki67, Cyclin D1 and grade III), a substantial number did not show this. This study provides clues to support the current hypothesis that several mechanisms drive the carcinogenesis of TNBC, with a heterogeneous pattern of biomarker expression. Further investigation is needed to better understand the factors driving the development and progression of the different types of TNBC. Citation Format: Adewunmi O. Adeoye, Bruce J. Youngson, Naomi Miller, Susan J. Done. Heterogeneity within triple-negative breast cancer (TNBC). [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1204. doi:10.1158/1538-7445.AM2013-1204

Research paper thumbnail of A Case of Compound Intussusceptions in a Nigerian Child - a Rare Finding in a Common Disease

PubMed, Jun 1, 2017

Intussusception is the most common, non-congenital, cause of intestinal obstruction in infants. T... more Intussusception is the most common, non-congenital, cause of intestinal obstruction in infants. There are various patterns of intussusception seen in children with the most common being ileo-colic variety. Compound intussusception in which intussusception involves more than one non-adjacent segment is a rare finding in the literature and it can be associated with worse morbidity than typically occurs, especially in a region where delayed presentation is a major contributor to morbidity and mortality in the treatment of intestinal obstruction. We report the first documented case of double compound intussusception in an African child and reviewed relevant literature.

Research paper thumbnail of A Case of Compound Intussusceptions in a Nigerian Child - a Rare Finding in a Common Disease

PubMed, Jun 1, 2017

Intussusception is the most common, non-congenital, cause of intestinal obstruction in infants. T... more Intussusception is the most common, non-congenital, cause of intestinal obstruction in infants. There are various patterns of intussusception seen in children with the most common being ileo-colic variety. Compound intussusception in which intussusception involves more than one non-adjacent segment is a rare finding in the literature and it can be associated with worse morbidity than typically occurs, especially in a region where delayed presentation is a major contributor to morbidity and mortality in the treatment of intestinal obstruction. We report the first documented case of double compound intussusception in an African child and reviewed relevant literature.

Research paper thumbnail of Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data

Introduction: TNBC has the highest mortality rate amongst all other breast cancer types due to it... more Introduction: TNBC has the highest mortality rate amongst all other breast cancer types due to its complex tumor heterogeneity and lack of well-defined molecular targets. It is known that women of African descent are two to three times more likely to develop TNBC compared to women of European ancestry, yet wide-scale genomic studies of African and African American breast tumors are limited. To elucidate genotypes and molecular subtypes associated with the most aggressive forms of breast cancer, we used the PAM50 NanoString platform to reclassify Nigerian (NG), African American (AA) and Caucasian (CA) tumors previously annotated by Immunohistochemistry (IHC), and correlated our findings to their germline genotype data obtained using high-throughput technologies. Methods: RNAs were isolated from formalin-fixed, paraffin embedded (FFPE) tumor tissues using the High Pure Paraffin Kit (Roche) following manufacturer's protocol, and assayed on NanoString nCounter Analysis System using a custom Nano110 (PAM50 + claudin-low & VEGF signatures) probe set. Intrinsic subtyping and gene-expression data were evaluated using R statistical software. All study samples were previously annotated and subtyped by the ER/PR/HER2 IHC classifier. Genotypes were obtained from next generation sequencing or Illumina Human2.5M BeadChip platform using germline DNA from more than 2000 breast cancer cases and 2000 controls were studied. Results: To date, Intrinsic molecular subtyping by Nano110 has been completed on 69 NG, 81 AA and 74 CA tumors. Concordance between IHC and PAM50 was 59%, which is adequate and comparable to previous studies. Basal-like subtype was overrepresented and accounted for nearly 30% of NG and AA cases, compared to 17% in CA cases. HER2-enriched subtype was overrepresented only in NG cases (9%). The proportion with Luminal A tumors were 44% NG, 56% AA and 68% CA, respectively. Conclusions: PAM50 NanoString assay is reliable and high-throughput for molecular subtyping breast cancer using RNA extracted from FFPE tumors. Ongoing work will correlate PAM50 intrinsic subtypes to genotype data. Citation Format: Olayiwola OA, Ogundiran TO, Hardeman A, Yoshimatsu TF, Clayton W, Adeoye A, Ademola A, Ajani MA, Khramtsova G, Grushko TA, Huo D, Zheng Y, Parker J, Perou C, Olopade OI. Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P6-04-05.

Research paper thumbnail of Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data

Introduction: TNBC has the highest mortality rate amongst all other breast cancer types due to it... more Introduction: TNBC has the highest mortality rate amongst all other breast cancer types due to its complex tumor heterogeneity and lack of well-defined molecular targets. It is known that women of African descent are two to three times more likely to develop TNBC compared to women of European ancestry, yet wide-scale genomic studies of African and African American breast tumors are limited. To elucidate genotypes and molecular subtypes associated with the most aggressive forms of breast cancer, we used the PAM50 NanoString platform to reclassify Nigerian (NG), African American (AA) and Caucasian (CA) tumors previously annotated by Immunohistochemistry (IHC), and correlated our findings to their germline genotype data obtained using high-throughput technologies. Methods: RNAs were isolated from formalin-fixed, paraffin embedded (FFPE) tumor tissues using the High Pure Paraffin Kit (Roche) following manufacturer's protocol, and assayed on NanoString nCounter Analysis System using a custom Nano110 (PAM50 + claudin-low & VEGF signatures) probe set. Intrinsic subtyping and gene-expression data were evaluated using R statistical software. All study samples were previously annotated and subtyped by the ER/PR/HER2 IHC classifier. Genotypes were obtained from next generation sequencing or Illumina Human2.5M BeadChip platform using germline DNA from more than 2000 breast cancer cases and 2000 controls were studied. Results: To date, Intrinsic molecular subtyping by Nano110 has been completed on 69 NG, 81 AA and 74 CA tumors. Concordance between IHC and PAM50 was 59%, which is adequate and comparable to previous studies. Basal-like subtype was overrepresented and accounted for nearly 30% of NG and AA cases, compared to 17% in CA cases. HER2-enriched subtype was overrepresented only in NG cases (9%). The proportion with Luminal A tumors were 44% NG, 56% AA and 68% CA, respectively. Conclusions: PAM50 NanoString assay is reliable and high-throughput for molecular subtyping breast cancer using RNA extracted from FFPE tumors. Ongoing work will correlate PAM50 intrinsic subtypes to genotype data. Citation Format: Olayiwola OA, Ogundiran TO, Hardeman A, Yoshimatsu TF, Clayton W, Adeoye A, Ademola A, Ajani MA, Khramtsova G, Grushko TA, Huo D, Zheng Y, Parker J, Perou C, Olopade OI. Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P6-04-05.

Research paper thumbnail of Orbital intravascular papillary endothelial hyperplasia in a Nigerian child: a case report and review of the literature

Journal of Medical Case Reports, Sep 13, 2012

Introduction: Intravascular papillary endothelial hyperplasia is a reactive proliferative lesion ... more Introduction: Intravascular papillary endothelial hyperplasia is a reactive proliferative lesion of endothelial cells in blood vessels. It typically presents as a painless, reddish purple lesion in the sites affected. The orbit remains an uncommon site of affectation of this relatively common disease. It is noteworthy that this is the first reported case, to the best of our knowledge, of orbital intravascular papillary endothelial hyperplasia in a Nigerian child. Case presentation: The case reported here is an orbital intravascular papillary endothelial hyperplasia causing non-axial proptosis and loss of vision in a 14-year-old Nigerian boy. We describe the clinical and histological findings of intravascular papillary endothelial hyperplasia in the orbit of this 14-year-old boy. The key distinguishing features are discussed and relevant literature is reviewed. Conclusion: Although unusual in presentation, intravascular papillary endothelial proliferation should be considered in the list of differentials of proptosis due to mass lesion in young Nigerians and, possibly, Africans.

Research paper thumbnail of Abstract 4747: Genomic alterations in ductal carcinoma in situ compared with Invasive breast cancer: a quantitative real-time PCR study

Introduction: Several molecular markers have been investigated as possible prognostic factors for... more Introduction: Several molecular markers have been investigated as possible prognostic factors for ductal carcinoma in situ (DCIS) progression to invasive ductal cancer (IDC). DCIS is regarded as a non-obligate precursor of IDC as it is frequently found adjacent to or surrounded by invasive breast cancer. Previously, we carried out genomic analyses that demonstrated that DCIS has specific genetic alterations that were conserved in invasive disease. Nevertheless, it is still unknown whether DCIS is merely a marker of increased risk, or actually a driver of the progression to IDC.Thus, it is crucial to better understand the genetic aberrations that underlie DCIS progression to IDC. Methodology: We conducted array chromosomal genomic hybridization on pure DCIS, IDC and DCIS paired with IDC, with 30 cases each (all were microdissected). Three chromosomal regions were selected based on the rate of their detection, which was significantly different (p<0.05) between tumors of different receptor status, whether in combination, or single parameter; ER, PgR, HER2. In total, 9 genes were chosen for further validation, spanning Chromosome 4p15.33, Chromosome 5q11.2 and Chromosome 5q31.3. Quantitative real-time polymerase chain reaction (Q-RT-PCR) was used to study the copy number state of the 9 genes in different pure cases, including 22 DCIS, 29 IDC and 10 DCIS paired with IDC (all were microdissected). All areas contained more than 90% carcinoma or control cells. By normalizing values to the housekeeping gene, human albumin, and normal control DNA samples, we obtained ΔΔCt values for each sample. Results: 61 samples were analyzed by comparing DCIS and IDC copy numbers of genes within the selected chromosomal regions. The median relative gene quantities were 1.66(4p15.33), 1.34(5q11.2) and 1.25(5q31.3). In all regions, IDC showed higher levels of amplification than DCIS with varying degrees of significance. Not all differences between DCIS and IDC in individual genes were significant. This observation may be attributed to focal variations in gene copy numbers and noise from Q-RT-PCR methods. 4p15.33 and 5q31.3 regions demonstrated significant gain in IDC compared to DCIS (p = 0.021). Genes within these regions include miRNA 572 (MIR572) and integrin alpha 2 (ITGA2). MIR572 is known to be involved in post-transcriptional regulation of gene expression, whereas ITGA2 encodes the alpha subunit of a transmembrane receptor for collagens. In the Chromosome 5q31.3 region, paired samples of DCIS and IDC also showed a trend in gene copy numbers, with IDC having a higher value than DCIS. Conclusions: Our findings demonstrate that there are specific genetic alterations associated with DCIS progression to IDC. In particular, MIR572 within Chromosome 4p15.33 and ITGA2 within Chromosome 5q31.3 may serve as candidate regions to predict the progression of DCIS to IDC. Note: This abstract was not presented at the meeting. Citation Format: Trillium E. Chang, Keisha Warren, Ranju Nair, Tian Y. Lu, Adewunmi Adeoye, Vladimir Iakovlev, Susan J. Done. Genomic alterations in ductal carcinoma in situ compared with Invasive breast cancer: a quantitative real-time PCR study. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4747. doi:10.1158/1538-7445.AM2015-4747

Research paper thumbnail of Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

Nature Communications, 2019

Research paper thumbnail of Abstract PD8-05: Comparative analysis of the genomic landscape of breast cancers from women of African and European ancestry

Cancer Research, 2017

Objectives: Paucity of data on populations of African Ancestry in clinical trials continues to li... more Objectives: Paucity of data on populations of African Ancestry in clinical trials continues to limit our ability to design and implement innovative solutions to narrow the breast cancer survival gap amongst Africans, African Americans, and European Americans. We have developed a cross-continent research infrastructure to examine the spectrum of genomic alterations in breast tumors from West Africa and subsequently, to compare them to tumors from African American women and women of European Ancestry in The Cancer Genome Atlas (TCGA) database. Methods: Consecutive women with breast cancer presenting for treatment at the University College Hospital, Ibadan and at Lagos State University Teaching Hospital, Lagos, Nigeria gave informed consent and were recruited to the West African Breast Cancer Study (WABCS) between 2013-2016. Tumor-normal pairs were subjected to exome and/or high-depth (90x) genome sequencing. High confidence somatic mutations (substitutions, insertions/deletions and st...

Research paper thumbnail of Abstract 4494: Whole genome sequencing reveals different patterns of mutational mechanisms in breast tumors between women of African and European descent

Cancer Research, 2016

Across race/ethnicities, breast cancer incidence and mortality rates markedly differ. Numerous st... more Across race/ethnicities, breast cancer incidence and mortality rates markedly differ. Numerous studies have demonstrated that individuals of African ancestry acquire aggressive, early-onset breast cancers more frequently than other populations for reasons that remain unexplained. The sources of these disparities are complex, and a comprehensive characterization of mutation landscapes amongst indigenous Africans, African Americans (AA), and Caucasian breast tumors has not been performed. We generated high-depth whole genome sequencing on 31 Nigerian breast cancers (90x) along with matched blood (30x). Breast cancer whole genomes (tumor-normal pairs) from The Cancer Genome Atlas were harmonized with our samples, resulting in a cohort of 31 Nigerians (17 estrogen receptor negative, ER-), 31 AA (22 ER-), and 43 Caucasians (19 ER-). High confidence somatic mutations (substitutions and insertions/deletions) were obtained by using multiple variant callers. Regardless of race, ER- tumors ca...

Research paper thumbnail of Abstract 2590: Development and validation of a breast cancer risk prediction model for black women: findings from the Nigerian breast cancer study

Cancer Research, 2016

Background: Breast cancer (BC) risk prediction models, such as the Gail model, have been develope... more Background: Breast cancer (BC) risk prediction models, such as the Gail model, have been developed and widely used to identify women at higher risk of having breast cancer in developed countries. However, no model exists for Black women of sub-Saharan Africa (SSA). Because African women have different risk profiles, it is of public health importance to develop a Black women-specific model. Methods: A total of 1,880 hospital-based cases and 2,166 population-based controls from the Nigerian Breast Cancer Study (NBCS, 1998∼2015) were included in the analysis. Subjects were randomly divided into the training (2/3 of the data) and validation sets (1/3 of the data), and multivariate logistic regressions were used to derive the model. Risk factors were selected based on previous NBCS findings and literature review. Calibration and discrimination performances were assessed using the observed/expected ratio (O/E) and concordance statistic (C-index), respectively. Results: The final model inc...

Research paper thumbnail of Diagnostic accuracy of tru-cut biopsy of breast lumps at University College Hospital, Ibadan

African journal of medicine and medical sciences, 2015

Tru-cut needle biopsies form an integral part of Triple assessment of breast cancer and include c... more Tru-cut needle biopsies form an integral part of Triple assessment of breast cancer and include clinical assessment, mammography and core needle biopsy. No study has been done to evaluate the validity of the procedure in our environment. This study was done to evaluate the validity of core needle biopsies in our centre. A retrospective study of patients with tru-cut needle biopsies of breast lumps and follow-up excisional biopsy or mastectomy done in the Department of Surgery, University College Hospital, Ibadan over a ten year period was done. Fifty one patients who fulfilled the inclusion criteria had their records obtained from the Department of Pathology. The diagnosis was classified into benign and malignant with the excisional biopsy or mastectomy diagnosis used as the gold standard. The sensitivity, specificity and accuracy were calculated and kappa was also done to evaluate the degree of agreement. A total of 51 cases were included in this study. The average age of the patie...

Research paper thumbnail of Correlation of intraoperative cytological and final histological diagnoses: A retrospective 10-year study of neurosurgical cases from Ibadan, Nigeria

Diagnostic Cytopathology, Aug 4, 2014

Intraoperative cytology is a cost-effective, rapid, and easy technique, and studies have shown go... more Intraoperative cytology is a cost-effective, rapid, and easy technique, and studies have shown good correlation between intraoperative cytology and histology. We undertook this study to compare the intraoperative cytology diagnoses of brain lesions made in our unit over a 10-year period with the definitive histological diagnoses. The aim was to determine the degree of accuracy of this procedure. Study design: This is a retrospective study of intraoperative neuropathology consultation cytology smears or imprints and histology of 69 cases obtained over a 10-year period. Cytology smears were stained using both Papanicolaou and Giemsa. Histology sections were prepared from routine formalin-fixed paraffin-embedded tissue and stained using H and E method. Each of the smears and histology samples were assessed by at least two pathologists. Cytological diagnosis was correlated with final histological diagnosis. The sensitivity and specificity of cytological diagnosis was evaluated using final histological diagnosis as gold standard. Results: Correlation was strongest with inflammatory lesions followed by low-grade neoplasms. High-grade neoplasms also showed good concordance, but the degree of correlation was lower than in the other categories. Misdiagnosis was commonest with benign tumors. Conclusion: Intraoperative cytology is a relatively simple, reliable, and accurate diagnostic technique and should be more commonly used, particularly in low-resource settings. Diagn.

Research paper thumbnail of Testicular ischemia secondary to epididymo-orchitis: A case report

Urology Case Reports, 2019

Testicular infarction is a common urological emergency in clinical practice, it is still underrep... more Testicular infarction is a common urological emergency in clinical practice, it is still underreported when it results from other than spermatic cord torsion. It rarely arises from other pathological processes like vasculitis and infectious disease. We report a case of 18-year-old with epididymo-orchitis complicated by testicular ischemia. This case accentuates the need for a high index of suspicion to rule out concomitant testicular ischemia secondary to epididymo-orchitis that might be salvaged in the future with immediate surgical intervention. Testicular infarction is a devastating complication from epididymo-orchitis that is difficult to predict and distinguish from more common presentations of acute scrotum.

Research paper thumbnail of Ultrasound-guided core biopsy of breast lesions in Ibadan: Our initial experience

Journal of Clinical Sciences, 2015

Background and Objectives: Ultrasound-guided core needle or tru-cut biopsy is a new concept in b... more Background and Objectives: Ultrasound-guided core needle or tru-cut biopsy is a new concept in breast cancer diagnosis and treatment in developing countries, including Nigeria. A tru-cut biopsy is less invasive surgery, replacing diagnostic surgical biopsies in many institutions. It has a known sensitivity of 94-100%, whether performed with ultrasound or stereotactic guidance. The technique is reliable, simple, reproducible, and relatively cheap. Aims: This is a premier report of ultrasound- guided core biopsy of the breast in Nigeria. This study will evaluate the sampling adequacy and diagnostic accuracy of sonomammographic-guided tru-cut biopsies in determining the nature of a breast lump sent for histopathological analysis. Materials and Methods: A prospective study involving 40 women with clinical suspicion of breast cancer and/or Breast Imaging-Reporting and Data System (BI-RADS) category 3-5 referred for breast imaging at the Department of Radiology of the University College Hospital, Ibadan. Core biopsy was performed with a manual BARD Magnum™ gun, a General Electric GE Logiq P5 ultrasound unit with a high frequency linear transducer. Statistical Package for social sciences [SPSS] Software version 17.0 was used for statistical analysis. Results: Forty core needle biopsies (CNB) were performed on palpable masses. Histopathology confirmed cancer in 24 (60%), while 10 (25%) were benign. Invasive ductal carcinoma accounted for 88% of cancers. Sensitivity and specificity of the core biopsies was found to be 100% and 80%, respectively. Conclusion: Ultrasound-guided biopsy for breast lesion assessment in our center shows high accuracy in determining the nature of a breast lump. Its routine use in countries with limited resources is recommended.

Research paper thumbnail of Clear cell adenocarcinoma of the male urethra: a case report

African Journal of Urology

Background Primary urethral cancer in males is rare. Clear cell adenocarcinoma is more rare. We r... more Background Primary urethral cancer in males is rare. Clear cell adenocarcinoma is more rare. We report a case in an African male suspected to have a urethral stricture. Case presentation A 66-year-old man presented in with preceding intermittent haematuria and acute urinary retention. Failed attempts at catheterisation necessitating a suprapubic catheter insertion raised the suspicion of a urethral stricture. Multiple irregular urethral filling defects were seen on a retrograde urethrogram. Urethroscopy revealed obstructing urethral masses. Histology reported clear cell adenocarcinoma. Conclusion Primary urethral cancer should be entertained as a differential diagnosis of a urethral stricture in a patient with haematuria, difficult urethral catheterisation and ambiguous urethrogram findings. Cystoscopy and biopsy are essential in the investigative work-up to make the distinction.

Research paper thumbnail of Unveiling the African Breast Cancer Genome: The West Africa Breast Cancer Study (WABCS)

Research paper thumbnail of Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

Nature communications, Oct 16, 2018

Racial/ethnic disparities in breast cancer mortality continue to widen but genomic studies rarely... more Racial/ethnic disparities in breast cancer mortality continue to widen but genomic studies rarely interrogate breast cancer in diverse populations. Through genome, exome, and RNA sequencing, we examined the molecular features of breast cancers using 194 patients from Nigeria and 1037 patients from The Cancer Genome Atlas (TCGA). Relative to Black and White cohorts in TCGA, Nigerian HR + /HER2 - tumors are characterized by increased homologous recombination deficiency signature, pervasive TP53 mutations, and greater structural variation-indicating aggressive biology. GATA3 mutations are also more frequent in Nigerians regardless of subtype. Higher proportions of APOBEC-mediated substitutions strongly associate with PIK3CA and CDH1 mutations, which are underrepresented in Nigerians and Blacks. PLK2, KDM6A, and B2M are also identified as previously unreported significantly mutated genes in breast cancer. This dataset provides novel insights into potential molecular mechanisms underlyin...

Research paper thumbnail of Abstract P6-03-17: Genomic landscape of breast cancers from women of African ancestry across the diaspora

Cancer Research, 2016

Objectives: Of all ethnic/racial groups, age-standardized mortality rate from breast cancer is hi... more Objectives: Of all ethnic/racial groups, age-standardized mortality rate from breast cancer is highest for African American women in the US for reasons that remain understudied. The paucity of genomic studies of breast tumors across the African Diaspora further restricts our understanding of the biology of breast cancer in underserved populations. To gain a better understanding of the genomic landscape of breast cancer in women of African Ancestry, we have developed a cross continent translational research infrastructure to examine the spectrum of genetic alterations in breast tumors from West Africa compared to the spectrum of alterations observed in tumors from African-American and other women who are predominantly white in The Cancer Genome Atlas (TCGA) dataset. Methods: Peripheral blood and breast cancer biopsy tissues were collected from 214 patients enrolled in the West Africa Breast Cancer Study (WABCS) at the University of Ibadan/University College Hospital (UI/UCH) and at L...

Research paper thumbnail of Abstract 1204: Heterogeneity within triple-negative breast cancer (TNBC)

Background: TNBC refers to those breast cancers which are negative for ER, PR and Her2/neu overex... more Background: TNBC refers to those breast cancers which are negative for ER, PR and Her2/neu overexpression, thereby unsuitable for hormone and trastuzumab therapy. Although TNBC overlap with basal-like breast cancers, these terms are not synonymous. We decided, in a single institution cohort, to develop a better understanding of the types of tumors that make up TNBC Materials and Methods: We carried out a clinicopathological study of a cohort of 192 patients diagnosed with TNBC at the University Health Network in 2007. Patient biodata, clinical and histopathological information of proven prognostic importance was retrieved from the records. Tissue microarrays were constructed from duplicate 0.6mm cores of representative tumour tissue and stained with 9 antibodies according to recommended protocols. The TMA slides were interpreted using the Allred method except for the Ki67 staining which was interpreted by the visual estimate method of assessing proportion of nuclei taking up stains. Results were tabulated and summary statistics was done to determine proportions. Results: The age-range is 28 - 99 years. The median and modal age group was 50 -59 years. 70.3% of the patients are aged between 40 and 69 years at the time of diagnosis. The tumour size range was 0.6cm to 16 cm. 41.67% are pT1, 51.04% are pT2 while 6.8% are pT3. Four patients had T4 tumor with skin and nipple involvement. The diagnosis was predominantly invasive ductal carcinoma (IDC) in 84.9% of patients. Metaplastic carcinoma (10.4%), pleomorphic lobular carcinoma (1.5%), and single cases of invasive lobular carcinoma (ILC), tubular, apocrine and poorly differentiated carcinoma were seen. DCIS is a prominent feature in 26.6% of the cases. The number of lymph nodes identified ranged from 0 - 46. 59.90% were in pN0 category, 16.7% in the pN1 category, pN2 - 8.3%, and 15.1% in pN3 category. Extra-nodal metastasis at diagnosis was found in 7.3% of patients. The tumour grade: Grade I - 1.55%, Grade II - 13.47% and Grade III 84.97%. CD44 was positive in 17.71%, p63 - 4.17%, p53 - 51.56%, e-cadherin - 81.77%, Vimentin - 77.60%, Cyclin D1 - 22.40%, BCL-2 - 19.27%, and androgen receptor (AR) - 5.73%. 43.75% of cases show proliferation rates of ≥15%, while 26.04% have proliferation rates of between 5% and ≤14%. Conclusion: While a large proportion of TNBCs show a high proliferation (Ki67, Cyclin D1 and grade III), a substantial number did not show this. This study provides clues to support the current hypothesis that several mechanisms drive the carcinogenesis of TNBC, with a heterogeneous pattern of biomarker expression. Further investigation is needed to better understand the factors driving the development and progression of the different types of TNBC. Citation Format: Adewunmi O. Adeoye, Bruce J. Youngson, Naomi Miller, Susan J. Done. Heterogeneity within triple-negative breast cancer (TNBC). [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1204. doi:10.1158/1538-7445.AM2013-1204

Research paper thumbnail of Abstract 1204: Heterogeneity within triple-negative breast cancer (TNBC)

Background: TNBC refers to those breast cancers which are negative for ER, PR and Her2/neu overex... more Background: TNBC refers to those breast cancers which are negative for ER, PR and Her2/neu overexpression, thereby unsuitable for hormone and trastuzumab therapy. Although TNBC overlap with basal-like breast cancers, these terms are not synonymous. We decided, in a single institution cohort, to develop a better understanding of the types of tumors that make up TNBC Materials and Methods: We carried out a clinicopathological study of a cohort of 192 patients diagnosed with TNBC at the University Health Network in 2007. Patient biodata, clinical and histopathological information of proven prognostic importance was retrieved from the records. Tissue microarrays were constructed from duplicate 0.6mm cores of representative tumour tissue and stained with 9 antibodies according to recommended protocols. The TMA slides were interpreted using the Allred method except for the Ki67 staining which was interpreted by the visual estimate method of assessing proportion of nuclei taking up stains. Results were tabulated and summary statistics was done to determine proportions. Results: The age-range is 28 - 99 years. The median and modal age group was 50 -59 years. 70.3% of the patients are aged between 40 and 69 years at the time of diagnosis. The tumour size range was 0.6cm to 16 cm. 41.67% are pT1, 51.04% are pT2 while 6.8% are pT3. Four patients had T4 tumor with skin and nipple involvement. The diagnosis was predominantly invasive ductal carcinoma (IDC) in 84.9% of patients. Metaplastic carcinoma (10.4%), pleomorphic lobular carcinoma (1.5%), and single cases of invasive lobular carcinoma (ILC), tubular, apocrine and poorly differentiated carcinoma were seen. DCIS is a prominent feature in 26.6% of the cases. The number of lymph nodes identified ranged from 0 - 46. 59.90% were in pN0 category, 16.7% in the pN1 category, pN2 - 8.3%, and 15.1% in pN3 category. Extra-nodal metastasis at diagnosis was found in 7.3% of patients. The tumour grade: Grade I - 1.55%, Grade II - 13.47% and Grade III 84.97%. CD44 was positive in 17.71%, p63 - 4.17%, p53 - 51.56%, e-cadherin - 81.77%, Vimentin - 77.60%, Cyclin D1 - 22.40%, BCL-2 - 19.27%, and androgen receptor (AR) - 5.73%. 43.75% of cases show proliferation rates of ≥15%, while 26.04% have proliferation rates of between 5% and ≤14%. Conclusion: While a large proportion of TNBCs show a high proliferation (Ki67, Cyclin D1 and grade III), a substantial number did not show this. This study provides clues to support the current hypothesis that several mechanisms drive the carcinogenesis of TNBC, with a heterogeneous pattern of biomarker expression. Further investigation is needed to better understand the factors driving the development and progression of the different types of TNBC. Citation Format: Adewunmi O. Adeoye, Bruce J. Youngson, Naomi Miller, Susan J. Done. Heterogeneity within triple-negative breast cancer (TNBC). [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1204. doi:10.1158/1538-7445.AM2013-1204

Research paper thumbnail of A Case of Compound Intussusceptions in a Nigerian Child - a Rare Finding in a Common Disease

PubMed, Jun 1, 2017

Intussusception is the most common, non-congenital, cause of intestinal obstruction in infants. T... more Intussusception is the most common, non-congenital, cause of intestinal obstruction in infants. There are various patterns of intussusception seen in children with the most common being ileo-colic variety. Compound intussusception in which intussusception involves more than one non-adjacent segment is a rare finding in the literature and it can be associated with worse morbidity than typically occurs, especially in a region where delayed presentation is a major contributor to morbidity and mortality in the treatment of intestinal obstruction. We report the first documented case of double compound intussusception in an African child and reviewed relevant literature.

Research paper thumbnail of A Case of Compound Intussusceptions in a Nigerian Child - a Rare Finding in a Common Disease

PubMed, Jun 1, 2017

Intussusception is the most common, non-congenital, cause of intestinal obstruction in infants. T... more Intussusception is the most common, non-congenital, cause of intestinal obstruction in infants. There are various patterns of intussusception seen in children with the most common being ileo-colic variety. Compound intussusception in which intussusception involves more than one non-adjacent segment is a rare finding in the literature and it can be associated with worse morbidity than typically occurs, especially in a region where delayed presentation is a major contributor to morbidity and mortality in the treatment of intestinal obstruction. We report the first documented case of double compound intussusception in an African child and reviewed relevant literature.

Research paper thumbnail of Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data

Introduction: TNBC has the highest mortality rate amongst all other breast cancer types due to it... more Introduction: TNBC has the highest mortality rate amongst all other breast cancer types due to its complex tumor heterogeneity and lack of well-defined molecular targets. It is known that women of African descent are two to three times more likely to develop TNBC compared to women of European ancestry, yet wide-scale genomic studies of African and African American breast tumors are limited. To elucidate genotypes and molecular subtypes associated with the most aggressive forms of breast cancer, we used the PAM50 NanoString platform to reclassify Nigerian (NG), African American (AA) and Caucasian (CA) tumors previously annotated by Immunohistochemistry (IHC), and correlated our findings to their germline genotype data obtained using high-throughput technologies. Methods: RNAs were isolated from formalin-fixed, paraffin embedded (FFPE) tumor tissues using the High Pure Paraffin Kit (Roche) following manufacturer's protocol, and assayed on NanoString nCounter Analysis System using a custom Nano110 (PAM50 + claudin-low & VEGF signatures) probe set. Intrinsic subtyping and gene-expression data were evaluated using R statistical software. All study samples were previously annotated and subtyped by the ER/PR/HER2 IHC classifier. Genotypes were obtained from next generation sequencing or Illumina Human2.5M BeadChip platform using germline DNA from more than 2000 breast cancer cases and 2000 controls were studied. Results: To date, Intrinsic molecular subtyping by Nano110 has been completed on 69 NG, 81 AA and 74 CA tumors. Concordance between IHC and PAM50 was 59%, which is adequate and comparable to previous studies. Basal-like subtype was overrepresented and accounted for nearly 30% of NG and AA cases, compared to 17% in CA cases. HER2-enriched subtype was overrepresented only in NG cases (9%). The proportion with Luminal A tumors were 44% NG, 56% AA and 68% CA, respectively. Conclusions: PAM50 NanoString assay is reliable and high-throughput for molecular subtyping breast cancer using RNA extracted from FFPE tumors. Ongoing work will correlate PAM50 intrinsic subtypes to genotype data. Citation Format: Olayiwola OA, Ogundiran TO, Hardeman A, Yoshimatsu TF, Clayton W, Adeoye A, Ademola A, Ajani MA, Khramtsova G, Grushko TA, Huo D, Zheng Y, Parker J, Perou C, Olopade OI. Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P6-04-05.

Research paper thumbnail of Abstract P6-04-05: Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data

Introduction: TNBC has the highest mortality rate amongst all other breast cancer types due to it... more Introduction: TNBC has the highest mortality rate amongst all other breast cancer types due to its complex tumor heterogeneity and lack of well-defined molecular targets. It is known that women of African descent are two to three times more likely to develop TNBC compared to women of European ancestry, yet wide-scale genomic studies of African and African American breast tumors are limited. To elucidate genotypes and molecular subtypes associated with the most aggressive forms of breast cancer, we used the PAM50 NanoString platform to reclassify Nigerian (NG), African American (AA) and Caucasian (CA) tumors previously annotated by Immunohistochemistry (IHC), and correlated our findings to their germline genotype data obtained using high-throughput technologies. Methods: RNAs were isolated from formalin-fixed, paraffin embedded (FFPE) tumor tissues using the High Pure Paraffin Kit (Roche) following manufacturer's protocol, and assayed on NanoString nCounter Analysis System using a custom Nano110 (PAM50 + claudin-low & VEGF signatures) probe set. Intrinsic subtyping and gene-expression data were evaluated using R statistical software. All study samples were previously annotated and subtyped by the ER/PR/HER2 IHC classifier. Genotypes were obtained from next generation sequencing or Illumina Human2.5M BeadChip platform using germline DNA from more than 2000 breast cancer cases and 2000 controls were studied. Results: To date, Intrinsic molecular subtyping by Nano110 has been completed on 69 NG, 81 AA and 74 CA tumors. Concordance between IHC and PAM50 was 59%, which is adequate and comparable to previous studies. Basal-like subtype was overrepresented and accounted for nearly 30% of NG and AA cases, compared to 17% in CA cases. HER2-enriched subtype was overrepresented only in NG cases (9%). The proportion with Luminal A tumors were 44% NG, 56% AA and 68% CA, respectively. Conclusions: PAM50 NanoString assay is reliable and high-throughput for molecular subtyping breast cancer using RNA extracted from FFPE tumors. Ongoing work will correlate PAM50 intrinsic subtypes to genotype data. Citation Format: Olayiwola OA, Ogundiran TO, Hardeman A, Yoshimatsu TF, Clayton W, Adeoye A, Ademola A, Ajani MA, Khramtsova G, Grushko TA, Huo D, Zheng Y, Parker J, Perou C, Olopade OI. Genotype-phenotype classification of triple negative breast cancers (TNBC) in women of African descent using the PAM50 NanoString platform and genomic data. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P6-04-05.

Research paper thumbnail of Orbital intravascular papillary endothelial hyperplasia in a Nigerian child: a case report and review of the literature

Journal of Medical Case Reports, Sep 13, 2012

Introduction: Intravascular papillary endothelial hyperplasia is a reactive proliferative lesion ... more Introduction: Intravascular papillary endothelial hyperplasia is a reactive proliferative lesion of endothelial cells in blood vessels. It typically presents as a painless, reddish purple lesion in the sites affected. The orbit remains an uncommon site of affectation of this relatively common disease. It is noteworthy that this is the first reported case, to the best of our knowledge, of orbital intravascular papillary endothelial hyperplasia in a Nigerian child. Case presentation: The case reported here is an orbital intravascular papillary endothelial hyperplasia causing non-axial proptosis and loss of vision in a 14-year-old Nigerian boy. We describe the clinical and histological findings of intravascular papillary endothelial hyperplasia in the orbit of this 14-year-old boy. The key distinguishing features are discussed and relevant literature is reviewed. Conclusion: Although unusual in presentation, intravascular papillary endothelial proliferation should be considered in the list of differentials of proptosis due to mass lesion in young Nigerians and, possibly, Africans.

Research paper thumbnail of Abstract 4747: Genomic alterations in ductal carcinoma in situ compared with Invasive breast cancer: a quantitative real-time PCR study

Introduction: Several molecular markers have been investigated as possible prognostic factors for... more Introduction: Several molecular markers have been investigated as possible prognostic factors for ductal carcinoma in situ (DCIS) progression to invasive ductal cancer (IDC). DCIS is regarded as a non-obligate precursor of IDC as it is frequently found adjacent to or surrounded by invasive breast cancer. Previously, we carried out genomic analyses that demonstrated that DCIS has specific genetic alterations that were conserved in invasive disease. Nevertheless, it is still unknown whether DCIS is merely a marker of increased risk, or actually a driver of the progression to IDC.Thus, it is crucial to better understand the genetic aberrations that underlie DCIS progression to IDC. Methodology: We conducted array chromosomal genomic hybridization on pure DCIS, IDC and DCIS paired with IDC, with 30 cases each (all were microdissected). Three chromosomal regions were selected based on the rate of their detection, which was significantly different (p<0.05) between tumors of different receptor status, whether in combination, or single parameter; ER, PgR, HER2. In total, 9 genes were chosen for further validation, spanning Chromosome 4p15.33, Chromosome 5q11.2 and Chromosome 5q31.3. Quantitative real-time polymerase chain reaction (Q-RT-PCR) was used to study the copy number state of the 9 genes in different pure cases, including 22 DCIS, 29 IDC and 10 DCIS paired with IDC (all were microdissected). All areas contained more than 90% carcinoma or control cells. By normalizing values to the housekeeping gene, human albumin, and normal control DNA samples, we obtained ΔΔCt values for each sample. Results: 61 samples were analyzed by comparing DCIS and IDC copy numbers of genes within the selected chromosomal regions. The median relative gene quantities were 1.66(4p15.33), 1.34(5q11.2) and 1.25(5q31.3). In all regions, IDC showed higher levels of amplification than DCIS with varying degrees of significance. Not all differences between DCIS and IDC in individual genes were significant. This observation may be attributed to focal variations in gene copy numbers and noise from Q-RT-PCR methods. 4p15.33 and 5q31.3 regions demonstrated significant gain in IDC compared to DCIS (p = 0.021). Genes within these regions include miRNA 572 (MIR572) and integrin alpha 2 (ITGA2). MIR572 is known to be involved in post-transcriptional regulation of gene expression, whereas ITGA2 encodes the alpha subunit of a transmembrane receptor for collagens. In the Chromosome 5q31.3 region, paired samples of DCIS and IDC also showed a trend in gene copy numbers, with IDC having a higher value than DCIS. Conclusions: Our findings demonstrate that there are specific genetic alterations associated with DCIS progression to IDC. In particular, MIR572 within Chromosome 4p15.33 and ITGA2 within Chromosome 5q31.3 may serve as candidate regions to predict the progression of DCIS to IDC. Note: This abstract was not presented at the meeting. Citation Format: Trillium E. Chang, Keisha Warren, Ranju Nair, Tian Y. Lu, Adewunmi Adeoye, Vladimir Iakovlev, Susan J. Done. Genomic alterations in ductal carcinoma in situ compared with Invasive breast cancer: a quantitative real-time PCR study. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4747. doi:10.1158/1538-7445.AM2015-4747

Research paper thumbnail of Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

Nature Communications, 2019

Research paper thumbnail of Abstract PD8-05: Comparative analysis of the genomic landscape of breast cancers from women of African and European ancestry

Cancer Research, 2017

Objectives: Paucity of data on populations of African Ancestry in clinical trials continues to li... more Objectives: Paucity of data on populations of African Ancestry in clinical trials continues to limit our ability to design and implement innovative solutions to narrow the breast cancer survival gap amongst Africans, African Americans, and European Americans. We have developed a cross-continent research infrastructure to examine the spectrum of genomic alterations in breast tumors from West Africa and subsequently, to compare them to tumors from African American women and women of European Ancestry in The Cancer Genome Atlas (TCGA) database. Methods: Consecutive women with breast cancer presenting for treatment at the University College Hospital, Ibadan and at Lagos State University Teaching Hospital, Lagos, Nigeria gave informed consent and were recruited to the West African Breast Cancer Study (WABCS) between 2013-2016. Tumor-normal pairs were subjected to exome and/or high-depth (90x) genome sequencing. High confidence somatic mutations (substitutions, insertions/deletions and st...

Research paper thumbnail of Abstract 4494: Whole genome sequencing reveals different patterns of mutational mechanisms in breast tumors between women of African and European descent

Cancer Research, 2016

Across race/ethnicities, breast cancer incidence and mortality rates markedly differ. Numerous st... more Across race/ethnicities, breast cancer incidence and mortality rates markedly differ. Numerous studies have demonstrated that individuals of African ancestry acquire aggressive, early-onset breast cancers more frequently than other populations for reasons that remain unexplained. The sources of these disparities are complex, and a comprehensive characterization of mutation landscapes amongst indigenous Africans, African Americans (AA), and Caucasian breast tumors has not been performed. We generated high-depth whole genome sequencing on 31 Nigerian breast cancers (90x) along with matched blood (30x). Breast cancer whole genomes (tumor-normal pairs) from The Cancer Genome Atlas were harmonized with our samples, resulting in a cohort of 31 Nigerians (17 estrogen receptor negative, ER-), 31 AA (22 ER-), and 43 Caucasians (19 ER-). High confidence somatic mutations (substitutions and insertions/deletions) were obtained by using multiple variant callers. Regardless of race, ER- tumors ca...

Research paper thumbnail of Abstract 2590: Development and validation of a breast cancer risk prediction model for black women: findings from the Nigerian breast cancer study

Cancer Research, 2016

Background: Breast cancer (BC) risk prediction models, such as the Gail model, have been develope... more Background: Breast cancer (BC) risk prediction models, such as the Gail model, have been developed and widely used to identify women at higher risk of having breast cancer in developed countries. However, no model exists for Black women of sub-Saharan Africa (SSA). Because African women have different risk profiles, it is of public health importance to develop a Black women-specific model. Methods: A total of 1,880 hospital-based cases and 2,166 population-based controls from the Nigerian Breast Cancer Study (NBCS, 1998∼2015) were included in the analysis. Subjects were randomly divided into the training (2/3 of the data) and validation sets (1/3 of the data), and multivariate logistic regressions were used to derive the model. Risk factors were selected based on previous NBCS findings and literature review. Calibration and discrimination performances were assessed using the observed/expected ratio (O/E) and concordance statistic (C-index), respectively. Results: The final model inc...

Research paper thumbnail of Diagnostic accuracy of tru-cut biopsy of breast lumps at University College Hospital, Ibadan

African journal of medicine and medical sciences, 2015

Tru-cut needle biopsies form an integral part of Triple assessment of breast cancer and include c... more Tru-cut needle biopsies form an integral part of Triple assessment of breast cancer and include clinical assessment, mammography and core needle biopsy. No study has been done to evaluate the validity of the procedure in our environment. This study was done to evaluate the validity of core needle biopsies in our centre. A retrospective study of patients with tru-cut needle biopsies of breast lumps and follow-up excisional biopsy or mastectomy done in the Department of Surgery, University College Hospital, Ibadan over a ten year period was done. Fifty one patients who fulfilled the inclusion criteria had their records obtained from the Department of Pathology. The diagnosis was classified into benign and malignant with the excisional biopsy or mastectomy diagnosis used as the gold standard. The sensitivity, specificity and accuracy were calculated and kappa was also done to evaluate the degree of agreement. A total of 51 cases were included in this study. The average age of the patie...

Research paper thumbnail of Correlation of intraoperative cytological and final histological diagnoses: A retrospective 10-year study of neurosurgical cases from Ibadan, Nigeria

Diagnostic Cytopathology, Aug 4, 2014

Intraoperative cytology is a cost-effective, rapid, and easy technique, and studies have shown go... more Intraoperative cytology is a cost-effective, rapid, and easy technique, and studies have shown good correlation between intraoperative cytology and histology. We undertook this study to compare the intraoperative cytology diagnoses of brain lesions made in our unit over a 10-year period with the definitive histological diagnoses. The aim was to determine the degree of accuracy of this procedure. Study design: This is a retrospective study of intraoperative neuropathology consultation cytology smears or imprints and histology of 69 cases obtained over a 10-year period. Cytology smears were stained using both Papanicolaou and Giemsa. Histology sections were prepared from routine formalin-fixed paraffin-embedded tissue and stained using H and E method. Each of the smears and histology samples were assessed by at least two pathologists. Cytological diagnosis was correlated with final histological diagnosis. The sensitivity and specificity of cytological diagnosis was evaluated using final histological diagnosis as gold standard. Results: Correlation was strongest with inflammatory lesions followed by low-grade neoplasms. High-grade neoplasms also showed good concordance, but the degree of correlation was lower than in the other categories. Misdiagnosis was commonest with benign tumors. Conclusion: Intraoperative cytology is a relatively simple, reliable, and accurate diagnostic technique and should be more commonly used, particularly in low-resource settings. Diagn.

Research paper thumbnail of Testicular ischemia secondary to epididymo-orchitis: A case report

Urology Case Reports, 2019

Testicular infarction is a common urological emergency in clinical practice, it is still underrep... more Testicular infarction is a common urological emergency in clinical practice, it is still underreported when it results from other than spermatic cord torsion. It rarely arises from other pathological processes like vasculitis and infectious disease. We report a case of 18-year-old with epididymo-orchitis complicated by testicular ischemia. This case accentuates the need for a high index of suspicion to rule out concomitant testicular ischemia secondary to epididymo-orchitis that might be salvaged in the future with immediate surgical intervention. Testicular infarction is a devastating complication from epididymo-orchitis that is difficult to predict and distinguish from more common presentations of acute scrotum.

Research paper thumbnail of Ultrasound-guided core biopsy of breast lesions in Ibadan: Our initial experience

Journal of Clinical Sciences, 2015

Background and Objectives: Ultrasound-guided core needle or tru-cut biopsy is a new concept in b... more Background and Objectives: Ultrasound-guided core needle or tru-cut biopsy is a new concept in breast cancer diagnosis and treatment in developing countries, including Nigeria. A tru-cut biopsy is less invasive surgery, replacing diagnostic surgical biopsies in many institutions. It has a known sensitivity of 94-100%, whether performed with ultrasound or stereotactic guidance. The technique is reliable, simple, reproducible, and relatively cheap. Aims: This is a premier report of ultrasound- guided core biopsy of the breast in Nigeria. This study will evaluate the sampling adequacy and diagnostic accuracy of sonomammographic-guided tru-cut biopsies in determining the nature of a breast lump sent for histopathological analysis. Materials and Methods: A prospective study involving 40 women with clinical suspicion of breast cancer and/or Breast Imaging-Reporting and Data System (BI-RADS) category 3-5 referred for breast imaging at the Department of Radiology of the University College Hospital, Ibadan. Core biopsy was performed with a manual BARD Magnum™ gun, a General Electric GE Logiq P5 ultrasound unit with a high frequency linear transducer. Statistical Package for social sciences [SPSS] Software version 17.0 was used for statistical analysis. Results: Forty core needle biopsies (CNB) were performed on palpable masses. Histopathology confirmed cancer in 24 (60%), while 10 (25%) were benign. Invasive ductal carcinoma accounted for 88% of cancers. Sensitivity and specificity of the core biopsies was found to be 100% and 80%, respectively. Conclusion: Ultrasound-guided biopsy for breast lesion assessment in our center shows high accuracy in determining the nature of a breast lump. Its routine use in countries with limited resources is recommended.

Research paper thumbnail of Clear cell adenocarcinoma of the male urethra: a case report

African Journal of Urology

Background Primary urethral cancer in males is rare. Clear cell adenocarcinoma is more rare. We r... more Background Primary urethral cancer in males is rare. Clear cell adenocarcinoma is more rare. We report a case in an African male suspected to have a urethral stricture. Case presentation A 66-year-old man presented in with preceding intermittent haematuria and acute urinary retention. Failed attempts at catheterisation necessitating a suprapubic catheter insertion raised the suspicion of a urethral stricture. Multiple irregular urethral filling defects were seen on a retrograde urethrogram. Urethroscopy revealed obstructing urethral masses. Histology reported clear cell adenocarcinoma. Conclusion Primary urethral cancer should be entertained as a differential diagnosis of a urethral stricture in a patient with haematuria, difficult urethral catheterisation and ambiguous urethrogram findings. Cystoscopy and biopsy are essential in the investigative work-up to make the distinction.

Research paper thumbnail of Unveiling the African Breast Cancer Genome: The West Africa Breast Cancer Study (WABCS)

Research paper thumbnail of Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

Nature communications, Oct 16, 2018

Racial/ethnic disparities in breast cancer mortality continue to widen but genomic studies rarely... more Racial/ethnic disparities in breast cancer mortality continue to widen but genomic studies rarely interrogate breast cancer in diverse populations. Through genome, exome, and RNA sequencing, we examined the molecular features of breast cancers using 194 patients from Nigeria and 1037 patients from The Cancer Genome Atlas (TCGA). Relative to Black and White cohorts in TCGA, Nigerian HR + /HER2 - tumors are characterized by increased homologous recombination deficiency signature, pervasive TP53 mutations, and greater structural variation-indicating aggressive biology. GATA3 mutations are also more frequent in Nigerians regardless of subtype. Higher proportions of APOBEC-mediated substitutions strongly associate with PIK3CA and CDH1 mutations, which are underrepresented in Nigerians and Blacks. PLK2, KDM6A, and B2M are also identified as previously unreported significantly mutated genes in breast cancer. This dataset provides novel insights into potential molecular mechanisms underlyin...